Diagnosis and Prognosis of Non-small Cell Lung Cancer based on Machine Learning Algorithms

被引:4
作者
Zhou, Yiyi [1 ]
Dong, Yuchao [1 ]
Sun, Qinying [1 ]
Fang, Chen [1 ]
机构
[1] Second Mil Med Univ, Affiliated Hosp 1, Shanghai Changhai Hosp, Dept Resp & Crit Care Med, Shanghai 200433, Peoples R China
关键词
Bioinformatics; machine learning algorithms; TOP2A; immune infiltration; immune cells; lung cancer; GENE-EXPRESSION; IDENTIFICATION; BIOMARKER; PACKAGE; TOP2A;
D O I
10.2174/1386207326666230110115804
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background Non-small cell lung cancer (NSCLC) has been the subject of intense scholarly debate. We aimed to identify the potential biomarkers via bioinformatics analysis. Methods Three datasets were downloaded from gene expression omnibus database (GEO). R software was applied to screen differentially expressed genes (DEGs)and analyze immune cell infiltrates. Gene set enrichment analysis (GSEA) showed significant function and pathway in two groups. The diagnostic markers were further investigated by multiple machine learning algorithms (least absolute shrinkage and selection operator (LASSO) and support vector machine-recursive feature elimination (SVM-RFE)). Various online analytic platforms were utilized to explore the expression and prognostic value of differential genes. Furthermore, western blotting was performed to test the effects of genes on cell proliferation in vitro. Results We identified 181 DEGs shared by two datasets and selected nine diagnostic markers. Those genes were also significantly overexpressed in the third dataset. Topoisomerase II alpha (TOP2A) is overexpressed in lung cancer and associated with a poor prognosis, which was confirmed using immunohistochemistry (IHC) and Western blotting. Additionally, TOP2A showed a negative correlation with immune cells, such as CD8(+) T cells, eosinophils and natural killer (NK) cell. Conclusion Collectively, for the first time, we applied multiple machine learning algorithms, online databases and experiments in vitro to show that TOP2A is a potential biomarker for lung adenocarcinoma and could facilitate the development of new treatment strategies.
引用
收藏
页码:2170 / 2183
页数:14
相关论文
共 42 条
[1]  
[Anonymous], Cancer Stat Facts: Lung and Bronchus Cancer
[2]   NCBI GEO: mining tens of millions of expression profiles - database and tools update [J].
Barrett, Tanya ;
Troup, Dennis B. ;
Wilhite, Stephen E. ;
Ledoux, Pierre ;
Rudnev, Dmitry ;
Evangelista, Carlos ;
Kim, Irene F. ;
Soboleva, Alexandra ;
Tomashevsky, Maxim ;
Edgar, Ron .
NUCLEIC ACIDS RESEARCH, 2007, 35 :D760-D765
[3]   Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer [J].
Carvalho, Robson Francisco ;
do Canto, Luisa Matos ;
Cury, Sarah Santiloni ;
Frostrup Hansen, Torben ;
Jensen, Lars Henrik ;
Rogatto, Silvia Regina .
CANCERS, 2021, 13 (21)
[4]   UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses [J].
Chandrashekar, Darshan S. ;
Bashel, Bhuwan ;
Balasubramanya, Sai Akshaya Hodigere ;
Creighton, Chad J. ;
Ponce-Rodriguez, Israel ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana .
NEOPLASIA, 2017, 19 (08) :649-658
[5]   Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLC [J].
Chen, Meng-Yu ;
Zeng, Yue-Can ;
Zhao, Xi-He .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
[6]   Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis [J].
Chen, Yingji ;
Jin, Longyu ;
Jiang, Zhibin ;
Liu, Suo ;
Feng, Wei .
FRONTIERS IN ONCOLOGY, 2021, 11
[7]   Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma [J].
Cheng, Yang ;
Hou, Kezuo ;
Wang, Yizhe ;
Chen, Yang ;
Zheng, Xueying ;
Qi, Jianfei ;
Yang, Bowen ;
Tang, Shiying ;
Han, Xu ;
Shi, Dongyao ;
Wang, Ximing ;
Liu, Yunpeng ;
Hu, Xuejun ;
Che, Xiaofang .
FRONTIERS IN ONCOLOGY, 2021, 11
[8]   Regularization Paths for Generalized Linear Models via Coordinate Descent [J].
Friedman, Jerome ;
Hastie, Trevor ;
Tibshirani, Rob .
JOURNAL OF STATISTICAL SOFTWARE, 2010, 33 (01) :1-22
[9]   Prognostic Value and Significant Pathway Exploration Associated with TOP2A Involved in Papillary Thyroid Cancer [J].
Gong, Mou-chun ;
Chen, Wei-qing ;
Jin, Zhao-qing ;
Lyu, Jia ;
Meng, Li-hao ;
Wu, Hai-yan ;
Chen, Fei-hua .
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 :3485-3496
[10]   Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF) [J].
Greillier, Laurent ;
Gauvrit, Manon ;
Paillaud, Elena ;
Girard, Nicolas ;
Montegut, Coline ;
Boulahssass, Rabia ;
Wislez, Marie ;
Pamoukdjian, Frederic ;
Corre, Romain ;
Cabart, Mathilde ;
Caillet, Philippe ;
Belaroussi, Yaniss ;
Frasca, Matthieu ;
Noize, Pernelle ;
Wang, Pascal ;
Mebarki, Soraya ;
Mathoulin-Pelissier, Simone ;
Couderc, Anne-Laure .
CANCERS, 2022, 14 (03)